The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2705 | 2015 |
Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2703 | 2014 |
Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556. e25, 2017 | 2360 | 2017 |
Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017 | 1655 | 2017 |
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 516 | 2020 |
SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response J Huang, AJ Hume, KM Abo, RB Werder, C Villacorta-Martin, ... Cell Stem Cell 27 (6), 962-973. e7, 2020 | 340 | 2020 |
A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 227 | 2021 |
Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome EJ Burks, TP Loughran Jr Blood reviews 20 (5), 245-266, 2006 | 150 | 2006 |
SARS-CoV-2 infection–associated hemophagocytic lymphohistiocytosis: An autopsy series with clinical and laboratory correlation A Prilutskiy, M Kritselis, A Shevtsov, I Yambayev, C Vadlamudi, Q Zhao, ... American journal of clinical pathology 154 (4), 466-474, 2020 | 144 | 2020 |
A graph-transformer for whole slide image classification Y Zheng, RH Gindra, EJ Green, EJ Burks, M Betke, JE Beane, ... IEEE transactions on medical imaging 41 (11), 3003-3015, 2022 | 119 | 2022 |
Actionable cytopathogenic host responses of human alveolar type 2 cells to SARS-CoV-2 RM Hekman, AJ Hume, RK Goel, KM Abo, J Huang, BC Blum, RB Werder, ... Molecular cell 80 (6), 1104-1122. e9, 2020 | 99 | 2020 |
CD4 (+) CD56 (+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells KK Reichard, EJ Burks, MK Foucar, CS Wilson, DS Viswanatha, ... The American journal of surgical pathology 29 (10), 1274-1283, 2005 | 82 | 2005 |
Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis A Staron, EJ Burks, JC Lee, S Sarosiek, JM Sloan, V Sanchorawala Blood advances 4 (5), 880-884, 2020 | 52 | 2020 |
Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia HL Evans, E Burks, D Viswanatha, RS Larson Human pathology 31 (10), 1266-1273, 2000 | 49 | 2000 |
Profiling micro RNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma CG Kowalik, DA Palmer, TB Sullivan, PA Teebagy, JM Dugan, ... BJU international 120 (3), 428-440, 2017 | 37 | 2017 |
Inflammatory myofibroblastic tumor of the uterus: an immunohistochemical study of 23 cases JA Bennett, S Croce, A Pesci, N Niu, K Van de Vijver, EJ Burks, E Burandt, ... The American Journal of Surgical Pathology 44 (11), 1441-1449, 2020 | 33 | 2020 |
Follicular pancreatitis: a distinct form of chronic pancreatitis—an additional mimic of pancreatic neoplasms RK Gupta, BH Xie, KT Patton, M Lisovsky, E Burks, SW Behrman, ... Human pathology 48, 154-162, 2016 | 24 | 2016 |
Actionable cytopathogenic host responses of human alveolar type 2 cells to SARS-CoV-2 RM Hekman, AJ Hume, RK Goel, KM Abo, J Huang, BC Blum, RB Werder, ... Molecular cell 81 (1), 212, 2021 | 20 | 2021 |
Pulmonary adenocarcinomas of low malignant potential: proposed criteria to expand the spectrum beyond adenocarcinoma in situ and minimally invasive adenocarcinoma I Yambayev, TB Sullivan, K Suzuki, Q Zhao, SE Higgins, OH Yilmaz, ... The American Journal of Surgical Pathology 45 (4), 567-576, 2021 | 16 | 2021 |
Perspectives in the treatment of LGL leukemia B EJ Leuk Res 29, 123-125, 2005 | 16 | 2005 |